Non-profit managed by the former CEO Anne Wojcicki, gained an offer to get 23AndMe

• 23Andme’s Kofounderi and former General Director Anne Wojcicki’n’n Non-Commercial, Genetic Test Company agreed to receive $ 305 million. Wojcicki’s return, probably the lawsuits. The Nonprofit, the TTAM Research Institute, says 23AndMe will comply with the privacy policy.

Swift and sudden drops and 23AndMe ended by a genetic-test company. Non-profit operated by the company’s co-founder and former CEO Anne Wojcicki came to an agreement Buy a company with a $ 305 million bid.

The end of Friday will see Wojcicki control all the company’s assets.

It has been revealed for a long time Wojcicki The company released in March would not restore control. Biotech company located in New York Rejeneron Pharmacy It was established for $ 256 million, but in the last round of the proposal, Wojcicki’s TTAM Research Institute came out of the top.

Sale of 23andme sales worth $ 6 billion at once, caused a wave Customer would happen with genetic data spent. About 15% of their customers, Some 1.9 million peopleYou wanted to delete the data from the company’s servers because it was submitted to 23And for bankruptcy in March. The sale of the company also attracted the interest of the home control committee, which is related to where the information can end.

Ttam says 23Andme’s “Privacy Policy and Law” will be eligible and “compulsory obligations” to create additional protection and privacy guarantees. They will include consumer-privacy Advisory Council.

23Antme’s problems, in 2023, the company watched a hack on the company. For example, an online post that offers information for sale, is less than 1% in a large database of Ashkenazi Jews, including those ancestors.

Wojcicki, although he was still a General Director, and offered a health company to a healthcare company, which will only make the company ancestral information and drug-making health care company.

Wojcicki first offered to buy a company in mid-2024. 23Andme Board rejected the company’s proposal to remove the company private, next EC Master.

The purchase of 23Andme by a group of Wojcicki is likely to spark the lawsuits. 23Andme an independent investor in the beginning of this year talked to Fortune 23Andme, Wojcicki, who is in charge to allow evaluation, said that the company can turn and buy it at a low price. I can’t understand “why there are no other suggestions,” the investor who asked him that his privacy was protected Fortune.

This story was first displayed Fortune.com

Source link